Lowering systolic blood pressure below 120 mm Hg reduces cardiovascular risk in the general population, but this benefit does not occur in people with diabetes, prior stroke, or frailty.
From The 120/80 Blood Pressure Target Is Wrong · videoSee the scientific wording
The cardiovascular benefit of targeting systolic blood pressure below 120 mm Hg does not extend to individuals with diabetes, prior stroke, or frailty.
Contradicted by evidence
Observational3 good-quality studies contradict this claim.
What the research says
3 studies reviewedSupporting (1)
Cohort StudyHuman2025
In people without diabetes, keeping blood pressure under 120 helped slow plaque buildup in the heart arteries, but in people with diabetes, it made no difference — so lowering blood pressure this much doesn't help them the same way.
Contradicting (2)
Randomized Controlled TrialHuman
The study found that lowering blood pressure below 120 mm Hg helped prevent heart attacks and strokes even in people with diabetes or prior stroke—exactly the opposite of what the claim says. It worked just as well for them as for others.
Cohort StudyHuman2025
The study found that even in older, frail diabetic patients, lowering blood pressure below 120 mm Hg still reduced heart attacks and strokes — just like in non-frail patients. So, frailty doesn’t block the benefit, which goes against the claim.
Quality-weighted scoring: we follow the GRADE framework — each study is rated High, Moderate, Low, or Very Low based on study design, methodology rigor, and risk of bias. A single high-quality RCT can outweigh several weaker observational studies.
Scores reflect study quality, not just count.
In people with diabetes, prior stroke, or frailty, blood vessels are already damaged and cannot repair themselves as well. When blood pressure is pushed very low, the vessels become too stressed and cannot adjust properly, so the heart and brain do not get better protection from damage.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting, 2 contradicting studies
Related videos
How Fit Body Science checks a claim
- 1
We isolate the claim
Health advice from videos, articles and studies is broken down into single, testable claims.
- 2
We find the research
Each claim is matched against peer-reviewed studies, with every source cited by DOI.
- 3
We grade the evidence
Studies are scored on methodology, statistical rigor, transparency and publication quality.
The fitness and health internet is full of confident claims. We check them against real research.
Every claim on this site is traced back to peer-reviewed studies, scored on methodology and reporting quality, and given a verdict you can audit yourself — sources, DOIs and all.
- Full evidence breakdown and mechanism chains
- Ask our AI anything about a claim or its studies
- Get notified when new research changes a verdict
Lowering systolic blood pressure below 120 mm Hg reduces cardiovascular risk in the general population, but this benefit does not occur in people with diabetes, prior stroke, or frailty.
Mechanism
3 studiesIn people with diabetes, prior stroke, or frailty, blood vessels are already damaged and cannot adjust to very low blood pressure. Pushing pressure even lower does not improve protection because the vessels are too weak to respond properly, and organs may not get enough blood flow.
In people with diabetes, prior stroke, or frailty, blood vessels are already damaged and cannot repair themselves as well. When blood pressure is pushed very low, the vessels become too stressed and cannot adjust properly, so the heart and brain do not get better protection from damage.
Chronic hyperglycemia in diabetes causes advanced glycation end-product accumulation in vascular basement membranes, reducing arterial compliance and impairing endothelial repair capacity
Prior stroke induces persistent microvascular dysfunction and loss of autoregulatory capacity in cerebral vasculature, limiting the ability to maintain perfusion under low perfusion pressure
Frailty is associated with systemic inflammation, reduced nitric oxide bioavailability, and diminished vascular smooth muscle responsiveness, which blunts vasodilatory adaptation to low blood pressure
Intensive blood pressure reduction below 120 mm Hg further reduces perfusion pressure in vessels with impaired autoregulation, leading to inadequate tissue oxygen delivery and increased ischemic injury in vulnerable organs
Evidence from Studies
Last searched 2mo ago
Supporting (1)
Community contributions welcome
In people without diabetes, keeping blood pressure under 120 helped slow plaque buildup in the heart arteries, but in people with diabetes, it made no difference — so lowering blood pressure this much doesn't help them the same way.
Contradicting (2)
Community contributions welcome
The study found that lowering blood pressure below 120 mm Hg helped prevent heart attacks and strokes even in people with diabetes or prior stroke—exactly the opposite of what the claim says. It worked just as well for them as for others.
The study found that even in older, frail diabetic patients, lowering blood pressure below 120 mm Hg still reduced heart attacks and strokes — just like in non-frail patients. So, frailty doesn’t block the benefit, which goes against the claim.
Score Breakdown
No multi-axis breakdown available yet. The overall Pro / Against score above is the best signal.
- No clinical evidence is available; the score reflects mechanistic plausibility only.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Systematic Review of Systolic Blood Pressure Targets Below 120 mm Hg in Populations with Diabetes, Prior Stroke, or Frailty
Population: Adults with diabetes, prior stroke, or frailty; Intervention: Systolic blood pressure target <120 mm Hg; Comparator: Systolic blood pressure target ≥120 mm Hg; Outcome: Composite cardiovascular events (MI, stroke, heart failure, cardiovascular death); Duration: Minimum 3 years; Study design: Aggregated data from all eligible RCTs comparing these targets in these subpopulations
Randomized Trial of Intensive vs Standard Blood Pressure Control in Older Adults with Diabetes and Frailty
Population: Adults aged 65+ with type 2 diabetes and clinical frailty; Intervention: Systolic BP target <120 mm Hg; Comparator: Systolic BP target 130–140 mm Hg; Outcome: First occurrence of non-fatal MI, non-fatal stroke, hospitalization for heart failure, or cardiovascular death; Duration: 4 years; Design: Double-blind, multicenter, stratified by diabetes type and frailty severity
Longitudinal Cohort Study of Systolic Blood Pressure Targets and Cardiovascular Outcomes in Individuals with Prior Stroke
Population: Adults with history of ischemic or hemorrhagic stroke; Intervention: Observed systolic BP <120 mm Hg vs ≥120 mm Hg; Comparator: Natural variation in BP control; Outcome: Recurrent stroke, MI, or cardiovascular death; Duration: Minimum 5 years; Design: Prospective, population-based cohort with annual BP measurements and adjudicated outcomes
Case-Control Study of Intensive Blood Pressure Control and Cardiovascular Events in Frail Elderly with Diabetes
Population: Frail elderly with diabetes; Cases: Individuals with new cardiovascular event in past 12 months; Controls: Matched individuals without event; Exposure: Prior systolic BP target <120 mm Hg (from medical records); Duration: Retrospective 2-year exposure window; Design: Hospital-based, matched on age, sex, diabetes duration, and comorbidities
Cross-Sectional Analysis of Systolic Blood Pressure Levels and Cardiovascular Biomarkers in Diabetic, Frail, and Stroke-Exposed Adults
Population: Adults with diabetes, prior stroke, or frailty; Intervention: None (observational); Exposure: Current systolic BP <120 mm Hg vs ≥120 mm Hg; Outcome: Biomarkers (NT-proBNP, hs-CRP, troponin); Duration: Single time point; Design: Population-based survey with clinical measurements and lab tests